Janssen Reports Top-Line Phase 3 Results For Tremfya® (Guselkumab) In Adults With Active Psoriatic Arthritis
- EMEA Innovative Medicine
- JANSSEN REPORTS TOP-LINE PHASE 3 RESULTS FOR TREMFYA® (GUSELKUMAB) IN ADULTS WITH ACTIVE PSORIATIC ARTHRITIS
JANSSEN REPORTS TOP-LINE PHASE 3 RESULTS FOR TREMFYA® (GUSELKUMAB) IN ADULTS WITH ACTIVE PSORIATIC ARTHRITIS
- X (Twitter)
Copy link